Dateline City:
WHITEHOUSE STATION, N.J.
Post-partum Hemorrhage Is Leading Cause of Mothers Dying
WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, and
Ferring Pharmaceuticals today announced their collaboration with the
World Health Organization (WHO) to advance a new, proprietary
formulation of carbetocin, used to prevent excessive bleeding
(post-partum hemorrhage) in women after childbirth, that is designed to
be stable at room temperature, even in hot and tropical climates (ICH
climatic zone IV).
Language:
English
Contact:
MerckMedia:Jennifer Allen Woodruff, 267-305- 3550orLainie Keller, 908-423-4187orInvestor:Carol Ferguson, 908-423-4465orFerring Media:Helen Gallagher, +41 58 301 0051orPatrick Gorman, +41 58 301 0053
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more